Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03644251 · ClinicalTrials.gov registry record · NA
FLO for Discogenic Pain
A NA study, sponsored by BioTissue Holdings.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT03644251 is a NA study that was terminated before completion, run by BioTissue Holdings. The registered enrollment target is 3 participants.
The verdict
NCT03644251, a NA study, was terminated before completion, sponsored by BioTissue Holdings.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
Discogenic pain is pain originating from a damaged vertebral disc and be caused by inflammation, dehydration of the nucleus pulposus, decreased disc height, annular tears and impaired mechanical function of the disc.Non-operative treatment may include traction, steroid therapy, methylene blue injection and ablative therapy. However, there are few high quality studies evaluating these treatments for reducing discogenic low back pain and most clinical trials failed to detect significant differences between treatments and placebo therapies. Hence, there remains an unmet clinical need.
Interventions
- OTHER amniotic and umbilical cord matrix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2018-08-13 |
| Est. Completion | 2019-03-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03644251
The ClinicalTrials.gov registry entry for NCT03644251 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BioTissue Holdings, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which amniotic and umbilical cord matrix is the first listed.
NCT03644251 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03644251 about?
NCT03644251 is a clinical study titled "FLO for Discogenic Pain". Discogenic pain is pain originating from a damaged vertebral disc and be caused by inflammation, dehydration of the nucleus pulposus, decreased disc height, annular tears and impaired mechanical function of the disc.Non-operative treatment may include traction, steroid therapy, methylene blue inject...
What is the current status of trial NCT03644251?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2018-08-13. Estimated completion is 2019-03-04.
What interventions are being tested in trial NCT03644251?
The interventions under investigation include: amniotic and umbilical cord matrix (OTHER).
Who is sponsoring clinical trial NCT03644251?
This trial is sponsored by BioTissue Holdings, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.